Home Jasper

Jasper

In operation
Seasoned Equity Offering
Developer and Producer of Conditioners and Therapeutics
Basic
Enterprise Profile

Basic Information

Jasper is a biotechnology company dedicated to providing safer conditioning agents and therapeutics to expand the application of curative hematopoietic stem cell transplantation and gene therapy. Jasper was co-founded by Judith Shizuru, MD, PhD, a hematopoietic stem cell transplantation expert from Stanford University, and Susan Prohaska, an immunologist, stem cell biologist, and early drug development expert from Stanford University.
Jasper Therapeutics, Inc.
Latvia
less than 15 people
January 01, 2018
info@jaspertherapeutics.com

Enterprise Profile

Industrial Sector
New Drug Development Drug Trial Scientific Research and Experimental Development Services
Technology
Gene Technology Immunological Techniques Cell Technology
Concept
Disease Treatment Immune System Diseases Hematologic Diseases
Application Scenarios
Innovative Drugs Prescription Drug Monoclonal Antibody